Eastern Bank’s Amylyx Pharmaceuticals AMLX Stock Holding History

Eastern Bank’s Portfolio AMLX Stock Details AMLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$21K	Hold	721	–	–	﹤0.01%	789
2026 Q2	$12.9K	Buy	721 +521	+261%	+$8.06K	﹤0.01%	836
2026 Q1	$2.78K	Buy	+200	New	+$2.81K	﹤0.01%	983

Other funds holding AMLX

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Eastern Bank's AMLX Position: Q3 2026 in Review

Eastern Bank held its Amylyx Pharmaceuticals (AMLX) position steady in Q3 2026 at 721 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #789.

Eastern Bank first reported a position in AMLX in Q1 2026 and has held it in 3 quarters since. 6 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.

Eastern Bank held 721 shares of Amylyx Pharmaceuticals worth $21K as of Q3 2026.
Eastern Bank left its Amylyx Pharmaceuticals share count unchanged in Q3 2026.
Amylyx Pharmaceuticals made up ﹤0.01% of Eastern Bank's portfolio in Q3 2026, its #789 holding.
Eastern Bank first reported a position in Amylyx Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
6 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.

Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.